Dealing With the CARDS of COVID-19*

The need to counter the global threat posed by coronavirus disease 2019 (COVID-19) has prompted unprecedented hi-speed sharing of clinical data, experience, and ideas geared to first understanding and then formulating an effective approach to treatment of the coronavirus disease-associated acute respiratory distress syndrome—let us call it “CARDS.” Consistent features have quickly emerged worldwide (1,2). Clinically, cough, and malaise and...